DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Erbitux (Cetuximab) - Serious Reactions - Suspected Cause - Side Effect Reports

 
 



Index of reports > Serious Reactions (467)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Erbitux (Cetuximab) serious reactions. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 467   Next >>

Possible Erbitux side effects in 51 year old male

Reported by a consumer/non-health professional from United States on 2012-08-27

Patient: 51 year old male

Reactions: Deafness Unilateral

Drug(s) suspected as cause:
Erbitux



Possible Erbitux side effects in 50 year old male

Reported by a consumer/non-health professional from Germany on 2012-08-21

Patient: 50 year old male

Reactions: Blood Pressure Increased, Blood Test Abnormal

Drug(s) suspected as cause:
Erbitux



Possible Erbitux side effects in male

Reported by a physician from Japan on 2012-08-20

Patient: male, weighing 61.0 kg (134.2 pounds)

Reactions: Paronychia, Fatigue, Neuropathy Peripheral, Stomatitis, Diarrhoea, Hyperkalaemia, Hypomagnesaemia, Dermatitis Bullous, Neutrophil Count Decreased

Drug(s) suspected as cause:
Erbitux

Other drugs received by patient: Irinotecan Hydrochloride; Leucovorin Calcium; Fluorouracil



Possible Erbitux side effects in 50 year old male

Reported by a physician from Germany on 2012-08-17

Patient: 50 year old male, weighing 55.0 kg (121.0 pounds)

Reactions: Gastrointestinal Haemorrhage

Drug(s) suspected as cause:
Erbitux



Possible Erbitux side effects in 63 year old female

Reported by a consumer/non-health professional from Israel on 2012-08-15

Patient: 63 year old female

Reactions: Platelet Count Decreased

Drug(s) suspected as cause:
Carboplatin
    Dosage: 100mg per m2
    Start date: 2012-06-14
    End date: 2012-06-24

Erbitux
    Dosage: total :890mg 5mg/ml is the strength last infu:19jun12
    Indication: Squamous Cell Carcinoma of THE Cervix
    Start date: 2012-06-19
    End date: 2012-06-24

Taxol
    Dosage: 50mg per m2
    Start date: 2012-06-14
    End date: 2012-06-24



Possible Erbitux side effects in male

Reported by a physician from France on 2012-08-08

Patient: male

Reactions: Phlebitis, Neuropathy Peripheral, Pulmonary Embolism, Asthenia, Disease Progression

Drug(s) suspected as cause:
Avastin
    Indication: Colon Cancer
    Start date: 2008-06-18
    End date: 2008-09-12

Erbitux
    Start date: 2010-05-03
    End date: 2010-09-21

Other drugs received by patient: Leucovorin Calcium; Leucovorin Calcium; Leucovorin Calcium; Fluorouracil; Fluorouracil; Fluorouracil; Oxaliplatin; Irinotecan Hydrochloride; Irinotecan Hydrochloride



Possible Erbitux side effects in 50 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-03

Patient: 50 year old male

Reactions: Agitation, Fatigue, Haemoptysis, Rash, Skin Fissures

Drug(s) suspected as cause:
Erbitux



Possible Erbitux side effects in 52 year old female

Reported by a consumer/non-health professional from Italy on 2012-08-03

Patient: 52 year old female

Reactions: Dermatitis Acneiform, Pruritus, Polyneuropathy

Drug(s) suspected as cause:
Eloxatin
    Indication: Colon Cancer
    Start date: 2011-09-28
    End date: 2012-03-12

Erbitux
    Dosage: 1 df:366 units nos,dose:200mg/m2 cyclical.
    Indication: Colon Cancer
    Start date: 2011-09-15
    End date: 2012-02-02

Other drugs received by patient: Fluorouracil; Leucovorin Calcium



Possible Erbitux side effects in

Reported by a consumer/non-health professional from Germany on 2012-08-02

Patient:

Reactions: Rectal Haemorrhage, Epistaxis

Drug(s) suspected as cause:
Erbitux



Possible Erbitux side effects in

Reported by a consumer/non-health professional from Germany on 2012-08-02

Patient:

Reactions: Myocardial Infarction

Drug(s) suspected as cause:
Erbitux



Possible Erbitux side effects in 59 year old female

Reported by a physician from Germany on 2012-08-01

Patient: 59 year old female

Reactions: Neutropenia, Nail Toxicity

Drug(s) suspected as cause:
Erbitux
    Dosage: reintroduced on 12-mar-2012
    Indication: Rectal Cancer
    Start date: 2010-08-19

Fluorouracil
    Dosage: reintroduced on 12-mar-2012
    Indication: Rectal Cancer
    Start date: 2010-08-19

Irinotecan Hydrochloride
    Dosage: reintroduced on 12-mar-2012
    Indication: Rectal Cancer
    Start date: 2010-08-19

Other drugs received by patient: Losartan Potassium



Possible Erbitux side effects in 59 year old female

Reported by a physician from Italy on 2012-07-31

Patient: 59 year old female

Reactions: Neutropenia, Nail Toxicity

Drug(s) suspected as cause:
Erbitux
    Dosage: 410 mg, cyclic
    Indication: Rectal Cancer
    Start date: 2010-08-19

Fluorouracil
    Dosage: 3710 mg, cyclic
    Indication: Rectal Cancer
    Start date: 2010-08-19

Irinotecan Hydrochloride
    Dosage: 240 mg, cyclic
    Indication: Rectal Cancer
    Start date: 2010-08-19

Other drugs received by patient: Losartan Potassium



Possible Erbitux side effects in 51 year old female

Reported by a physician from Germany on 2012-07-30

Patient: 51 year old female, weighing 54.0 kg (118.8 pounds)

Reactions: Endocarditis, Device Related Infection, Cardiac Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Erbitux



Possible Erbitux side effects in 64 year old female

Reported by a physician from Italy on 2012-07-30

Patient: 64 year old female

Reactions: Diarrhoea, Rash

Drug(s) suspected as cause:
Erbitux
    Dosage: 680 mg, cyclic
    Indication: Colon Cancer
    Start date: 2012-01-14
    End date: 2012-07-24

Irinotecan Hydrochloride
    Dosage: 310 mg, cyclic
    Indication: Colon Cancer
    Start date: 2012-01-14
    End date: 2012-07-24

Other drugs received by patient: Norvasc; Omeprazole; Enalapril Maleate; Femara; Effexor



Possible Erbitux side effects in 50 year old male

Reported by a consumer/non-health professional from Germany on 2012-07-27

Patient: 50 year old male

Reactions: Gastrointestinal Haemorrhage

Drug(s) suspected as cause:
Erbitux



Possible Erbitux side effects in 64 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-24

Patient: 64 year old male, weighing 111.0 kg (244.2 pounds)

Reactions: Dermatitis Acneiform, Weight Decreased, Dyspnoea, Dysphonia, Recall Phenomenon, Pneumonia Staphylococcal, Myocardial Infarction

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Erbitux
    Dosage: arm 1:400mg/m2,iv:120 min,day 1,other chemo/radiation that day/week.last adminstered:30oct06,540mg
    Indication: Head and Neck Cancer
    Start date: 2006-10-30
    End date: 2006-10-30

Taxotere
    Dosage: total dose: 32 mg,last administered:30oct2006
    Indication: Head and Neck Cancer
    Start date: 2006-10-30
    End date: 2006-10-30



Possible Erbitux side effects in

Reported by a consumer/non-health professional from Germany on 2012-07-23

Patient:

Reactions: Upper Gastrointestinal Haemorrhage

Drug(s) suspected as cause:
Erbitux



Possible Erbitux side effects in 68 year old female

Reported by a consumer/non-health professional from Germany on 2012-07-20

Patient: 68 year old female, weighing 52.0 kg (114.4 pounds)

Reactions: Blood Immunoglobulin G Increased, Arthralgia, Bone Pain

Drug(s) suspected as cause:
Erbitux

Other drugs received by patient: Ondansetron; Polaramine; Primperan TAB; Fluorouracil; Atropine; Calcium; Irinotecan HCL; Methylprednisolone; Zopiclone



Possible Erbitux side effects in

Reported by a consumer/non-health professional from Germany on 2012-07-18

Patient:

Reactions: Hyperpyrexia, Thrombocytopenia

Drug(s) suspected as cause:
Erbitux

Other drugs received by patient: Irinotecan HCL



Possible Erbitux side effects in 82 year old female

Reported by a consumer/non-health professional from United States on 2012-07-18

Patient: 82 year old female

Reactions: Thrombosis, Nasopharyngitis, Neoplasm Malignant, Asthenia

Drug(s) suspected as cause:
Erbitux
    Dosage: was recieved once in every 1 week
    Indication: Colon Cancer

Warfarin Sodium



Possible Erbitux side effects in 51 year old female

Reported by a physician from Italy on 2012-07-18

Patient: 51 year old female

Reactions: Nausea, DRY Skin, Alopecia Areata, Hypertransaminasaemia

Drug(s) suspected as cause:
Erbitux
    Indication: Rectal Cancer
    Start date: 2010-07-23

Fluorouracil
    Indication: Rectal Cancer
    Start date: 2010-07-23

Irinotecan Hydrochloride
    Indication: Rectal Cancer
    Start date: 2010-07-23

Other drugs received by patient: Leucovorin Calcium



Possible Erbitux side effects in 72 year old male

Reported by a consumer/non-health professional from United States on 2012-07-16

Patient: 72 year old male, weighing 76.0 kg (167.2 pounds)

Reactions: Weight Decreased, Acne Pustular, Dyspnoea, Haemorrhage, Diarrhoea, Hypotension, Rash, Full Blood Count Decreased, Infusion Related Reaction

Drug(s) suspected as cause:
Erbitux
    Dosage: second infusion was on 09may2012 :860 iv dose:860(units no.s).
    Indication: Colon Cancer Metastatic
    Start date: 2012-04-18

Irinotecan HCL



Possible Erbitux side effects in 74 year old male

Reported by a consumer/non-health professional from Germany on 2012-07-16

Patient: 74 year old male

Reactions: Intestinal Obstruction

Drug(s) suspected as cause:
Erbitux



Possible Erbitux side effects in 70 year old male

Reported by a physician from Germany on 2012-07-13

Patient: 70 year old male

Reactions: Leukocytoclastic Vasculitis

Drug(s) suspected as cause:
Erbitux

Other drugs received by patient: Fluorouracil; Carboplatin



Possible Erbitux side effects in 55 year old male

Reported by a consumer/non-health professional from United States on 2012-07-13

Patient: 55 year old male

Reactions: Death, Back Pain, Dysphagia, Dehydration, Cough

Adverse event resulted in: death

Drug(s) suspected as cause:
Erbitux
    Indication: Head and Neck Cancer

Erbitux
    Indication: Hepatic Neoplasm Malignant

Other drugs received by patient: Methadone HCL; Ibuprofen; Vicodin



Possible Erbitux side effects in 60 year old female

Reported by a physician from United Kingdom on 2012-07-12

Patient: 60 year old female, weighing 61.0 kg (134.2 pounds)

Reactions: Dermatitis Acneiform, Intestinal Ischaemia, Intestinal Perforation

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Erbitux
    Dosage: route: also iv drip
    Indication: Colorectal Cancer Metastatic
    Start date: 2005-11-16
    End date: 2006-03-16

Irinotecan HCL
    Dosage: route: also iv drip
    Indication: Colorectal Cancer Metastatic
    Start date: 2005-11-16
    End date: 2006-03-16



Possible Erbitux side effects in male

Reported by a consumer/non-health professional from United States on 2012-07-11

Patient: male

Reactions: Tracheostomy

Drug(s) suspected as cause:
Erbitux



Possible Erbitux side effects in

Reported by a consumer/non-health professional from Germany on 2012-07-11

Patient:

Reactions: Pneumatosis Intestinalis

Drug(s) suspected as cause:
Erbitux
    Dosage: infusion

Irinotecan HCL



Possible Erbitux side effects in

Reported by a consumer/non-health professional from Germany on 2012-07-11

Patient:

Reactions: Ileus Paralytic

Drug(s) suspected as cause:
Erbitux

Other drugs received by patient: Irinotecan HCL



Possible Erbitux side effects in 51 year old female

Reported by a physician from Italy on 2012-07-11

Patient: 51 year old female

Reactions: Nausea, Alopecia, DRY Skin, Hypertransaminasaemia

Drug(s) suspected as cause:
Erbitux
    Dosage: 630 mg, cyclic
    Indication: Rectal Cancer
    Start date: 2010-07-23

Fluorouracil
    Dosage: 4100 mg, cyclic
    Indication: Rectal Cancer
    Start date: 2010-07-23

Irinotecan HCL
    Dosage: 280 mg, cyclic
    Indication: Rectal Cancer
    Start date: 2010-07-23

Other drugs received by patient: Calcium Folinate



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012